5 September 2016 - The EMA has published an EPAR for Teva Pharmaceuticals' version of GSK's Seretide/Advair.
The European Commission approved Aerivio Spiromax on 18 August 2016 for use by certain patients with asthma or chronic obstructive pulmonary disease.